Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Shulman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neurology|February 21, 2007
Steroid dementia: a follow-upOliver Sacks, Melanie Shulman
Neurology|February 25, 2005
Steroid dementia: an overlooked diagnosis?Oliver Sacks, Melanie Shulman
Dementia and Geriatric Cognitive Disorders|January 26, 2017
Comprehensive, Individualized, Person-Centered Management of Community-Residing Persons with Moderate-to-Severe Alzheimer Disease: A Randomized Controlled TrialBarry Reisberg, Yongzhao Shao, James Golomb, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Understanding recent advances in non-amyloid/non-tau (NANT) biomarkers and therapeutic targets in Alzheimer's diseaseLinda J Van Eldik, Eric R Siemers, Emily C Collins, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentMelanie Shulman, Shuang Wu, Jing Xie, et al.
Nature Aging|November 27, 2023
TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer's diseaseMelanie Shulman, Jessica Kong, John O'Gorman, et al.
Nature Aging|February 11, 2026
Exploratory analyses of clinical outcomes from the BIIB080 phase 1b study in mild Alzheimer's diseaseMelanie Shulman, Shuang Wu, Nick Ziogas, et al.
JAMA Neurology|October 30, 2023
Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical TrialAmanda L Edwards, Jessica A Collins, Candice Junge, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neurology|February 21, 2007
Steroid dementia: a follow-upOliver Sacks, Melanie Shulman
Neurology|February 25, 2005
Steroid dementia: an overlooked diagnosis?Oliver Sacks, Melanie Shulman
Dementia and Geriatric Cognitive Disorders|January 26, 2017
Comprehensive, Individualized, Person-Centered Management of Community-Residing Persons with Moderate-to-Severe Alzheimer Disease: A Randomized Controlled TrialBarry Reisberg, Yongzhao Shao, James Golomb, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Understanding recent advances in non-amyloid/non-tau (NANT) biomarkers and therapeutic targets in Alzheimer's diseaseLinda J Van Eldik, Eric R Siemers, Emily C Collins, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentMelanie Shulman, Shuang Wu, Jing Xie, et al.
Nature Aging|November 27, 2023
TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer's diseaseMelanie Shulman, Jessica Kong, John O'Gorman, et al.
Nature Aging|February 11, 2026
Exploratory analyses of clinical outcomes from the BIIB080 phase 1b study in mild Alzheimer's diseaseMelanie Shulman, Shuang Wu, Nick Ziogas, et al.
JAMA Neurology|October 30, 2023
Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical TrialAmanda L Edwards, Jessica A Collins, Candice Junge, et al.
Pageof 1